Key result
Heparin-induced thrombocytopenia linked to ~$4,800 higher healthcare costs and prolonged hospital stays.
Why the study?
Heparin-induced thrombocytopenia is a serious adverse drug reaction associated with increased length of hospital stay and healthcare utilization, particularly when heparin-induced thrombotic thrombocytopenia occurs.
Case-Control (n=170)
No
Answers are grounded in this paper and cite their sources.
Heparin-induced thrombocytopenia (HIT) and HITT are associated with increased length of hospital stay and healthcare utilization.
Heparin-induced thrombocytopenia (HIT) is a serious adverse drug reaction associated with an increased length of hospital stay (LOS) and utilization of healthcare services and even more so if heparin-induced thrombotic thrombocytopenia (HITT) occurs.
No takes yet. Share an insight, caveat, or question.
Al-Eidan FA (2015) conducted a case-control in Heparin-Induced Thrombocytopenia (n=170). Heparin-Induced Thrombocytopenia (HIT) vs. Matched control subjects without HIT was evaluated on Total healthcare cost (US$) (Attributable cost $4829, p=<0.001). Heparin-induced thrombocytopenia was significantly associated with increased healthcare costs (median $9,469 vs $4,640) and a longer length of hospital stay (median 25 vs 13 days) compared to matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: